GKOSのチャート
GKOSの企業情報
| symbol | GKOS |
|---|---|
| 会社名 | Glaukos Corp （GLAUKOS CORPRTN） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | グラウコス(Glaukos Corporation)は眼科医療技術会社である。同社は緑内障の治療用製品の開発・商品化を行う。同社はマイクロ侵襲性緑内障手術（MIGS）装置であるiStentを提供する。iStentは、白内障手術中に作られた小さな角膜切開部を通って挿入され、房水を集めて血流に戻す循環チャネルであるシュレム管に配置されたマイクロバイパスステントである。同社はiStent Inject、iStent Supra、iDoseの3つの追加パイプライン製品を開発する。iStent Injectには、自動注入インサータにプリロードされた2つのステントが含まれる。iStent Supraは、目の中の代替排水スペースにアクセスするように設計される。iDoseは、緑内障患者の眼内圧を低下させるために治療レベルの薬物を長期間にわたって連続的に送達するために眼に埋め込まれるように設計された薬物送達システムである。 グロコスは米国の眼科医療機器メ―カ―。失明の一因である緑内障の治療のための製品や技術の商業化に焦点を当てる。同社はMIGS(超低侵襲な緑内障手術)のパイオニア。主要製品は顕微手術に使用されるチタン製極小管(マイクロバイパス・デバイス)の「iStent」で、FDAに認可されている。本社はカリフォルニア州。 Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent, its first MIGS device, in the United States in 2012, its next-generation iStent inject device in the United States in 2018, and most recently, the iStent inject W device in 2020. In corneal health, Glaukos' proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease. |
| 本社所在地 | 229 Avenida Fabricante San Clemente CA 92672 USA |
| 代表者氏名 | William J. Link |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 949-367-9600 |
| 設立年月日 | 35977 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 437人 |
| url | www.glaukos.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） -6.73800 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 2825.00300 |
| 売上高 | （百万ドル） 181.27800 |
| 企業価値(EV) | （百万ドル） 2684.51500 |
| 当期純利益 | （百万ドル） -12.95100 |
| 決算概要 | BRIEF: For the fiscal year ended 31 December 2018 Glaukos Corp revenues increased 14% to $181.3M. Net loss increased from $92K to $13M. Revenues reflect International segment increase of 61% to $29.6M United States segment increase of 8% to $151.7M. Higher net loss reflects Selling general and administrative increase of 20% to $99.7M (expense) Research and development increase of 27% to $44.5M (expense). |
GKOSのテクニカル分析
GKOSのニュース
Glaukos Corporation PT Lowered to $68 at Stephens 2022/12/28 12:34:06 Investing.com
https://www.investing.com/news/pro/glaukos-corporation-pt-lowered-to-68-at-stephens-432SI-2970698
Glaukos Corporation (GKOS) is an excellent investment, but the stock is overvalued/undervalued right now 2022/12/26 17:24:00 US Post News
In Friday’s session, Glaukos Corporation (NYSE:GKOS) marked $42.63 per share, down from $43.08 in the previous session. While Glaukos Corporation has underperformed by -1.04%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GKOS fell by -8.91%, with highs and lows ranging from $64.49 to $33.33, whereas […]
Mizuho Securities Starts Glaukos Corporation at Neutral 2022/12/22 10:27:06 Investing.com
https://www.investing.com/news/pro/mizuho-securities-starts-glaukos-corporation-at-neutral-432SI-2969123
First Look Analysts Research Calls for Monday, December 19 2022/12/19 13:07:48 24/7 Wall street
This report was sent to Briefing.com subscribers earlier today. Upgrades: > American Equity Investment Life (AEL) upgraded to Strong Buy from Outperform at Raymond James; tgt $48 > Enphase Energy (ENPH) upgraded to Outperform from Market Perform at Northland Capital; tgt $365 > Glaukos (GKOS) upgraded to Neutral from Underweight at JP Morgan; tgt lowered […]
Analysts Offer Important Insight On Glaukos Corporation (GKOS) 2022/12/17 17:00:00 Stocks Register
Glaukos Corporation (NYSE:GKOS) concluded the trading at $42.48 on Friday, December 16 with a fall of -1.94% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $43.32 and 5Y monthly beta was reading 1.29 with its price kept floating in the range … Analysts Offer Important Insight On Glaukos Corporation (GKOS) Read More »
Glaukos: Show Me The Money (NYSE:GKOS) 2022/11/10 15:00:44 Seeking Alpha
Glaukos shares fall post Q3 earnings announcement despite top-line guidance hike. Click here to read my analysis of GKOS stock.
Glaukos Announces Participation in the Stephens Annual Investment Conference 2022/11/07 12:00:00 Kwhen Finance
Glaukos Corp Earnings Miss, Revenue Beats In Q3 By Investing.com 2022/11/05 04:05:00 Investing.com
Glaukos Corp Earnings Miss, Revenue Beats In Q3
Glaukos Corporation (GKOS) Q3 2022 Earnings Call Transcript 2022/11/05 02:26:17 Seeking Alpha
Glaukos Corporation (NYSE:NYSE:GKOS) Q3 2022 Earnings Conference Call November 02, 2022 04:30 PM ET Company Participants Chris Lewis - Vice President-Investor Relations & Corporate…
Glaukos Corporation Announces Third Quarter 2022 Financial Results 2022/11/02 20:05:00 Business Wire
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the third quarter ended September 30, 2022. Key highlights include: Net sales of $71.3 million in Q3 2022. Glaucoma net sales of $53.7 million and Corneal Health net sales of $17.5 million in Q3 2022. Gross margin of approximately
Stephens Resumes Glaukos Corporation at Overweight 2022/10/13 20:29:01 Investing.com
https://www.investing.com/news/pro/stephens-resumes-glaukos-corporation-at-overweight-432SI-2911944
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting 2022/09/28 11:00:00 Wallstreet:Online
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, being held September 30 - October 3, 2022 in Chicago,
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday 2022/09/08 09:26:06 Benzinga
Gainers IMARA Inc. (NASDAQ: IMRA ) jumped 74.8% to settle at $2.01 on Wednesday after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront. Azure Power Global Limited (NYSE: AZRE ) shares jumped 35.4% to close at $4.86. Azure Power Global recently announced the resignation of Harsh Shah as CEO. SelectQuote, Inc. (NYSE: SLQT ) rose 28.8% to close at $1.43. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH ) gained 27.7% to close at $36.40 amid post-IPO volatility. Spero Therapeutics, Inc. (NASDAQ: SPRO ) shares jumped 26.6% to close at $1.43. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr. a.k.a. Brands Holding Corp. (NYSE: AKA ) gained 23.7% to settle at $2.92 amid overall market strength as stocks rebound from recent weakness.
Coupa Software, Glaukos rise; Occidental Petroleum falls 2022/09/07 20:14:34 WNYT
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday: EQT Corp., up 57 cents to $46. The natural gas company announced the purchase of gas and pipeline assets and doubled its stock buyback program. Coupa Software Inc., up $10 to $65.82. The software company reported strong second-quarter financial results. HealthEquity Inc., up 64 cents to $64.08. The provider of services for managing health care accounts raised its revenue forecast for the year. Occidental Petroleum Corp., down $1.45 to $65.43. Energy stocks slipped along with falling oil prices. Target Corp., up $7.21 to $170.79. The retailer is dropping the mandatory retirement age for its CEO, allowing Brian Cornell to stay on for three more years. United Parcel Service Inc., up 33 cents to $196.29. The package delivery service plans to hire more than 100,000 extra workers to help handle an increase in packages during the critical holiday season. Glaukos Corp., up $8.91 to $57.01. The drug developer gave investors an encouraging update on a potential glaucoma treatment.
Dow Jumps 450 Points; UiPath Shares Slide 2022/09/07 18:42:28 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday. The Dow traded up 1.45% to 31,596.87 while the NASDAQ rose 1.99% to 11,774.77. The S&P 500 also rose, gaining, 1.74% to 3,976.30. Also check this: Fear & Greed Index Remains In ''Fear'' Zone As US Stocks Drop Leading and Lagging Sectors Utilities shares jumped by 2.6% on Tuesday. Meanwhile, top gainers in the sector included Azure Power Global Limited (NYSE: AZRE ), up 32% and Sunnova Energy International Inc. (NYSE: NOVA ) up 10%. In trading on Tuesday, energy shares fell by 1.5%. Top Headline The trade deficit narrowed by $10.2 billion to a nine-month low level of $70.7 billion in July. Exports from the US rose by 0.2% from the prior month to $259.3 billion, while imports fell 2.9% to $329.9 billion. Equities Trading UP Glaukos Corporation (NYSE: GKOS ) shares shot up 25% to $60.29 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety …